Essentia Health in Duluth now has a new tool to help diagnose Alzheimer’s, and it’s the first of its kind in the Northland. The amyloid PET Scan machine helps detect signs of the plaques that build up ...
ST. LOUIS--(BUSINESS WIRE)--New research finds that C₂N Diagnostics, LLC’s proprietary algorithm used in its PrecivityAD2 blood test, which is used by healthcare providers to determine Alzheimer’s ...
January 18, 2011 — Findings on positron emission tomography (PET) using the radiotracer florbetapir F 18 correlate with the presence and quantity of brain β-amyloid pathology found at autopsy, a new ...
Findings showed 91.7% of patients with positive results using Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio test had amyloid plaques based on PET scan or CSF test results. The Food and Drug ...
A research group has investigated how Alzheimer's disease can be diagnosed more reliably in the future. A research group at LMU University Hospital has investigated how Alzheimer's disease can be ...
The FDA has approved the first blood test to detect signs of Alzheimer’s disease, marking a major step toward easier diagnosis. The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio test identifies ...
Quantification of amyloid beta neuritic plaque levels can now be used in conjunction with visual assessment in the updated label. The Food and Drug Administration (FDA) has approved an updated label ...
Share on Pinterest A new study suggests that PET brain scans could help identify individuals at risk of cognitive decline, allowing them to receive earlier intervention. Reza Estakhrian/Getty Images ...
Detailed price information for Algernon Health Inc A (AGNPF) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results